Results 161 to 170 of about 66,967 (213)

Identification and Computational Analysis of <i>BRCA2</i> Variants in Mexican Women from Jalisco, Mexico, with Breast and Ovarian Cancer. [PDF]

Med Sci (Basel)
García-Verdín PM, García-Ortiz JE, Garibaldi-Ríos AF, Dávalos-Rodríguez IP, Mendoza-Ruvalcaba SDC, Magaña-Torres MT, Figuera LE, Rosales-Reynoso MA, Tovar-Jácome CJ, Zúñiga-González GM, Gómez-Meda BC, Torres-Mendoza BM, Villegas-Pacheco R, Gómez-Cerda R, Cárdenas Valdez JC, Meza-Chavolla SO, Gallegos-Arreola MP.   +16 more
europepmc   +1 more source

Mutagenesis of the PALB2 WD40 domain identifies variants defective in interaction with BRCA2 and DNA repair. [PDF]

J Biol Chem
Gomes TT, Elias ABR, Huang H, Hu C, Nepomuceno TC, de Gregoriis G, Chrispim DS, Skaf LB, Szpunar FARL, Suarez-Kurtz G, Couch FJ, Monteiro ANA, Carvalho MA.   +12 more
europepmc   +1 more source

Updated analysis of pathogenic variants in BRCA1/BRCA2 among the general Japanese population. [PDF]

Hum Genome Var
Mariya T, Idogawa M, Saito T, Nakase H, Tokino T, Sakurai A.   +5 more
europepmc   +1 more source

Prevalence and Clinical Associations of Germline DDR Variants in Prostate Cancer: Real-World Evidence from a 122-Patient Turkish Cohort. [PDF]

Genes (Basel)
Akay S, Ozdemir TR, Ozer Kaya O, Degirmenci M, Unal OU.   +4 more
europepmc   +1 more source

A predictive model based on BRCA1/2, POLE, TP53, and MSH6 mutations for immunotherapy response in advanced endometrial cancer. [PDF]

Am J Cancer Res
Jia Y, Jia H, Mao X, Long X, Yue P, Ye M.   +5 more
europepmc   +1 more source

Different association of gBRCA1 and gBRCA2 variants with HER2-low status in invasive breast cancer: findings from a Ukrainian study. [PDF]

Sci Rep
Livshun S, Kozakov D, Kruhlykovа A, Koshyk O, Kobyliak N, Seleznov O, Matvieieva A, Shparyk Y, Volodko N, Zavizion V, Khmel A, Kharchenko K, Otchenash N, Andriiv A, Sulaieva O.   +14 more
europepmc   +1 more source

<i>BRCA</i> and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR⁺/HER2^- breast cancer with germline <i>BRCA1/2</i> mutations: a narrative review. [PDF]

Transl Breast Cancer Res
Illia MF, Colucci G, Rodriguez Mignola A, Eiben M, Ballester AM, Zeff N, Paesani F, Crimi G, Von Stecher F, de la Vega M, Perazzo F, Mandó P.   +11 more
europepmc   +1 more source

Novel Insights into the Enigmatic Genetics of Male Breast Cancer in China. [PDF]

Pathophysiology
Lang GT, Weng XL, Liu Y, Hu X, Shao ZM, Hu Z.   +5 more
europepmc   +1 more source

Patenting the Fingerprint of God: How Gene Patents Violate the Products of Nature Doctrine [PDF]

, 2015
Todd, Timothy M.
core   +1 more source

Targeting FGFR1 enhances olaparib sensitivity via MAPK-mediated BRCA2 downregulation in mCRPC. [PDF]

Transl Androl Urol
Chen J, Lai J, Chen Y, Long Y, Han Z, Su J, Zhou R, Zhou Z, He H, Liu S, Zhong W.   +10 more
europepmc   +1 more source